You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Leukemia,%20Plasma%20Cell

Showing 9951 - 9975 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Vitamin D Status in Sickle Cell Disease Living in Lyon, France

Recruiting
  • Vitamin D Deficiency
  • Sickle Cell Disease
  • 25-OH Vitamin D measure
  • Bron, France
    Hôpital Femme Mère enfant - Urgences pédiatriques
Feb 10, 2022

Diminished Ovarian Reserve, Ovarian Failure Trial in New York (A-PRP)

Recruiting
  • Diminished Ovarian Reserve
  • Ovarian Failure
  • A-PRP
  • New York, New York
    Center For Human Reproduction
Mar 8, 2022

Lymphoma Trial in Worldwide (Glofitamab, Tocilizumab, Doxorubicin)

Recruiting
  • Lymphoma
  • Duarte, California
  • +13 more
Aug 18, 2022

Non Small Cell Lung Cancer Trial in China (AZD3759)

Completed
  • Non Small Cell Lung Cancer
  • Guangzhou, Guangdong, China
  • +3 more
Nov 22, 2022

Acute Myeloid Leukemia (AML) Trial in Nantes (Tocilizumab)

Active, not recruiting
  • Acute Myeloid Leukemia (AML)
  • Nantes, France
    CHU of Nantes
Dec 16, 2022

Heart Transplantation Trial in Madrid (Autologous thyTreg)

Recruiting
  • Heart Transplantation
  • Autologous thyTreg
  • Madrid, Spain
    Hospital General Universitario Gregorio Marañon
Dec 5, 2022

Oral Cavity Squamous Cell Carcinoma, Stage I Lip and Oral Cavity Cancer AJCC v8, Stage II Lip and Oral Cavity Cancer AJCC v8

Not yet recruiting
  • Oral Cavity Squamous Cell Carcinoma
  • +4 more
  • Near Infrared Imaging
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 5, 2022

T-cell Lymphoma Patients After First-line Treatment Failure Trial (SHR2554; Chidamide analog tablets, SHR2554 analog tablets;

Not yet recruiting
  • T-cell Lymphoma Patients After First-line Treatment Failure
  • SHR2554; Chidamide analog tablets
  • SHR2554 analog tablets; Chidamide
  • (no location specified)
Nov 5, 2023

MDS Trial (Imetelstat)

Available
  • Myelodysplastic Syndromes
  • (no location specified)
Jun 30, 2023

Thalassemia Major Trial (n-acetylcystine)

Not yet recruiting
  • Thalassemia Major
  • (no location specified)
Mar 9, 2023

Oral Squamous Cell Carcinoma, Neoadjvant Therapy, Anti-PD-1 Trial in Shanghai (Toripalimab (anti-programmed death-1 inhibitor),

Recruiting
  • Oral Squamous Cell Carcinoma
  • +3 more
  • Toripalimab (anti-programmed death-1 inhibitor)
  • +4 more
  • Shanghai, Shanghai, China
    Ninth People's Hospital, Shanghai Jiao Tong University School of
Oct 8, 2022

COVID-19 Trial in Philadelphia (Convalescent Plasma)

Completed
  • COVID-19
  • Convalescent Plasma
  • Philadelphia, Pennsylvania
    Thomas Jefferson University Hospital
Jun 3, 2021

Head and Neck Squamous Cell Carcinoma, Radiotherapy, Immunotherapy Trial in Wuhan (induction therapy; surgery; radiotherapy)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +3 more
  • induction therapy; surgery; radiotherapy
  • Wuhan, Hubei, China
    Hubei Cancer Hospital
Jul 25, 2022

HIV-1 Trial (Doravirine, Darunavir, Ritonavir)

Active, not recruiting
Has Results
  • HIV-1
  • (no location specified)
Aug 19, 2022

Heart Failure Trial in Grand Rapids

Recruiting
  • Heart Failure
    • Grand Rapids, Michigan
      Frederik Meijer Heart Center
    Nov 23, 2022

    Hematology Biobank : Invitro Study of Blood Disorders

    Recruiting
    • Hematological Disorders
      • Bronx, New York
        Montefiore Medical Center
      Nov 14, 2022

      Multiple Sclerosis, Primary Progressive Trial in Worldwide (Ocrelizumab, Placebo)

      Recruiting
      • Multiple Sclerosis, Primary Progressive
      • Scottsdale, Arizona
      • +197 more
      Jan 2, 2023

      Heart Failure Trial in Berlin (Treatment A, Treatment B, Treatment C)

      Completed
      • Heart Failure
      • Treatment A
      • +7 more
      • Berlin, Germany
        Research Site
      Sep 8, 2021

      Hepatocellular Carcinoma Trial in Jinan (PD-1 plus stereotactic body radiotherapy)

      Recruiting
      • Hepatocellular Carcinoma
      • PD-1 plus stereotactic body radiotherapy
      • Jinan, Shandong, China
        Shandong Cancer Hospital and Institute
      May 3, 2022

      Thrombotic Microangiopathy Trial in Worldwide (Ravulizumab, Placebo, Best supportive care)

      Recruiting
      • Thrombotic Microangiopathy
      • Ravulizumab
      • +2 more
      • Tampa, Florida
      • +90 more
      Jan 26, 2023

      Lung Cancer Trial in Hanover (Remotely Supervised Exercise (REM), Unsupervised Exercise (UNSUP))

      Terminated
      • Lung Cancer
      • Remotely Supervised Exercise (REM)
      • Unsupervised Exercise (UNSUP)
      • Hanover, New Hampshire
        Dartmouth Hitchcock Medical Center
      Jan 28, 2021

      Relapsed/Refractory Diffuse Large B Cell Lymphoma, Relapsed/Refractory Primary Mediastinal B Cell Lymphoma, Relapsed/Refractory

      Approved for marketing
      • Relapsed/Refractory Diffuse Large B Cell Lymphoma
      • +3 more
      • Axicabtagene Ciloleucel
      • Duarte, California
      • +14 more
      Aug 30, 2022

      Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular, Lymphoma, Mantle-Cell Trial in Austria, Switzerland (BeEAM, BEAM)

      Completed
      • Lymphoma, Large B-Cell, Diffuse
      • +2 more
      • Linz, Austria
      • +3 more
      Jul 29, 2021

      The Optimization of Haploidentical Hematopoietic Stem Cell

      Not yet recruiting
      • Hematological Malignancy
      • ATG
      • Post-transplantation cyclophosphamide
      • Beijing, Beijing, China
        People's Hospital of Peking University
      Nov 28, 2022

      Oral Mucositis, Hematopoietic Tumor, Xerostomia Trial in Porto Alegre (Photobiomodulation therapy (intraoral),

      Recruiting
      • Oral Mucositis
      • +3 more
      • Photobiomodulation therapy (intraoral)
      • Photobiomodulation therapy (extraoral)
      • Porto Alegre, Rio Grande Do Sul, Brazil
        Federal University of Rio Grande do Sul
      Mar 7, 2023